Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rached

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
ESMO Open|October 22, 2023
Bridging the gap: addressing disparities of access to oncology clinical trials in the geriatric populationL Rached, M Frelaut, C Baldini
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2011
[Multiple sclerosis and urolithiasis]L Rached, B Lacour, M Daudon
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancerL Rached, F Peyre-Pradat, M Spotti, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
ESMO Open|October 22, 2023
Bridging the gap: addressing disparities of access to oncology clinical trials in the geriatric populationL Rached, M Frelaut, C Baldini
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2011
[Multiple sclerosis and urolithiasis]L Rached, B Lacour, M Daudon
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancerL Rached, F Peyre-Pradat, M Spotti, et al.
Pageof 1